Cost Effective Management of CKD-MBD: An Observational Study

  title={Cost Effective Management of CKD-MBD: An Observational Study},
  author={P JallahBorefore},
  • P JallahBorefore
  • Published 2015
  • Medicine
  • Chronic Kidney Disease and Mineral Bone Disorder (CKD-MBD) is often present in dialysis patients and is associated with increased hospitalization, cardiovascular morbidity and mortality. It is manifested by abnormalities in serum calcium, phosphate, parathyroid hormone (PTH) or vitamin D metabolism. Multiple interventions that often interact are possible to change biochemical parameters. The choice of treatment can greatly affect both biochemical outcomes and possibly also cost. The aim of this… CONTINUE READING


    Mortality in kidney disease patients treated with phosphate binders: a randomized study.
    • 188
    • PDF
    Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
    • 153
    Vitamin D affects survival independently of vascular calcification in chronic kidney disease.
    • 142
    • PDF
    Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies.
    • 228
    Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    • 2,312
    • PDF
    Magnesium in Chronic Kidney Disease: Challenges and Opportunities
    • 68
    Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients
    • P. Bolasco
    • Medicine
    • International journal of nephrology
    • 2011
    • 9
    • PDF
    Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
    • 473
    Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    • F. Tentori, M. Blayney, +9 authors F. Port
    • Medicine
    • American journal of kidney diseases : the official journal of the National Kidney Foundation
    • 2008
    • 827
    Metabolic bone disease in chronic kidney disease.
    • 191
    • PDF